Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Superior custom Liposomal formulation for best absorption and bioavailability
It delivers exceptional absorption and stability compared to standard glutathione formats, maximizing bioavailability and efficacy
In May 2025, Guayak Yerba Mate rebranded under the new name Yerba Madre
Retatrutide GLP-3 Vial All Retatrutide GLP-3 research Retatrutide (development code LY3437943) is a synthetic, once-weekly triple agonist of the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors that has been the subject of peer-reviewed phase 1 and phase 2 randomized controlled trials published in The New England Journal of Medicine, The Lancet, and Nature Medicine, including investigations of body weight, glycemic control, and hepatic steatosis in adult human participants
Reduces production of the hormone that increases fasting sugar (glucagon), optimising fasting sugar levels
US$ 25.06
US$ 29.41
US$ 24.55
US$ 21.11
US$ 26.93
